Reach Us +441474556909
Nanotechnology For Regenerative Medicine: Increasing Tissue Growth, Decreasing Infection, And Inhibiting Inflammation | 6559
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Nanotechnology for regenerative medicine: Increasing tissue growth, decreasing infection, and inhibiting inflammation

International Conference and Exhibition on Nanotechnology & Nanomedicine

Thomas J. Webster

ScientificTracks Abstracts: J Nanomedic Nanotechnol

DOI: 10.4172/2157-7439.S1.02

This presentation will summarize studies which have demonstrated enhanced in vitro and in vivo tissue growth on nanostructured metals, ceramics, polymers, and composites thereof compared to currently-used (nano-smooth) implants. Tissue growth to be emphasized will consist of bone, cartilage, vascular, skin, bladder, nervous system, and other tissues. These results strongly imply that nanomaterials may improve tissue regeneration compared to what is being implanted today. This review will also focus on a fundamental explanation of why tissue growth is enhanced on nanostructured compared to conventional tissue engineering materials summarizing a wide range of research efforts, including those which have already received FDA approval for implantation. In addition, recent studies on the use of nanoparticles to reduce infection and inflammation will be presented. Thoughts on the necessary future studies for the field of nanotechnology and tissue engineering to progress will also be presented
Thomas J. Webster is an associate professor for the School of Engineering and Department of Orthopaedics at Brown University. His degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995) and in biomedical engineering from Rensselaer (M.S., 1997; Ph.D., 2000). Prof. Webster has graduated over 51 post-doctoral students and thesis completing B.S., M.S., and Ph.D. students. To date, his lab group has generated 8 textbooks, 48 book chapters, 233 invited presentations, at least 343 peer-reviewed literature articles and/or conference proceedings, at least 504 conference presentations, and 24 provisional or full patents. His research has formed 6 companies